Related references
Note: Only part of the references are listed.Endometrial Cancer and BRCA Mutations: A Systematic Review
Maria Luisa Gasparri et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study
Marthe M. de Jonge et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort study
Sarah J. Kitson et al.
EUROPEAN JOURNAL OF CANCER (2020)
Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity
Marthe M. de Jonge et al.
CLINICAL CANCER RESEARCH (2019)
Hysterectomy at the time of risk-reducing surgery in BRCA carriers
Navya Nair et al.
GYNECOLOGIC ONCOLOGY REPORTS (2018)
Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers
Y. C. Lee et al.
EUROPEAN JOURNAL OF CANCER (2017)
Linking uterine serous carcinoma to BRCA1/2-associated cancer syndrome: A meta-analysis and case report
M. M. de Jonge et al.
EUROPEAN JOURNAL OF CANCER (2017)
Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers
Laura J. Havrilesky et al.
GYNECOLOGIC ONCOLOGY (2017)
Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy
Claire Saule et al.
JNCI-Journal of the National Cancer Institute (2017)
Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy
Claire Saule et al.
JNCI-Journal of the National Cancer Institute (2017)
Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening
S. Paluch-Shimon et al.
ANNALS OF ONCOLOGY (2016)
Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
Amy P. M. Finch et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: An international prospective cohort study
Yakir Segev et al.
GYNECOLOGIC ONCOLOGY (2013)
Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers
Welmoed Reitsma et al.
MODERN PATHOLOGY (2013)
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data
Jack Cuzick et al.
LANCET (2013)
Relationship between tamoxifen use and high risk endometrial cancer histologic types
Amy E. Bland et al.
GYNECOLOGIC ONCOLOGY (2009)
Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions
J. Wen et al.
ONCOGENE (2009)
The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations.: A prospective study
Mario E. Beiner et al.
GYNECOLOGIC ONCOLOGY (2007)
Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: An Israeli population-based case-control study
JL Rutter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Risk of endometrial carcinoma associated with BRCA mutation
DA Levine et al.
GYNECOLOGIC ONCOLOGY (2001)
Share Paper
